Bridging the gap: the need to integrate psychosocial oncology services into cancer genetics

Abstract Cancer susceptibility genes were first cloned over 25 years ago, prompting the initiation of cancer genetics services. Individuals with a strong family history suggesting inherited cancer susceptibility were referred for pretest genetic counseling, with specialist services typically based in academic centers. However, genetic information is now being used to inform personalized medicine approaches to oncology care, ranging from surgical decision making to selection of therapeutic agents for precision treatment. Receiving genetic information is life altering, with relevance for mortality and health practices. The psychosocial impacts of genetic information on individuals and their family have been well documented. Adverse psychological reactions are less common within an applied framework, including clear information and emotional support. Genetics services often occur separate from oncology teams and would benefit from further integration with psychosocial care. Psycho-oncology team members are primed to bring the relevant expertise. Recommendations are offered to help bridge the current gap in psychosocial care.